NCT06730438 · RECRUITING

Transcranial Pulse Stimulation. a Potential Treatment for Early Dementia

This study tests whether Transcranial Pulse Stimulation, a device that sends short magnetic-free sound-based pulses through the skull, is linked to better thinking and memory in people with early dementia. Phase is not applicable because it is a device study. That means it is still being explored, not proven or approved for this use. Details are limited so far.

You may qualify if

  • age>18 years
  • diagnosis of early dementia according to current international guidelines
  • disease duration of at least 12 months
  • consent to participate in the study.

You're excluded if

  • medical instability interfering with standard neurological assessment
  • any contraindication to preliminary MRI for MR-based real-time neuronavigation
  • comorbidities which may interfere with cognitive status
  • any contraindication to Transcranial Pulse Stimulation.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-12-16

View full record on ClinicalTrials.gov

All APOE4 clinical trials